Human papillomavirus type 16/18 up-regulates the expression of interleukin-6 and antiapoptotic Mcl-1 in non-small cell lung cancer

Keyphrases

• Interleukin-6 100%
• Non-small Cell Lung Cancer (NSCLC) 100%
• Anti-apoptotic 100%
• HPV16 100%
• Myeloid Cell leukemia-1 (Mcl-1) 100%
• Papillomavirus Infections 30%
• A549 Cells 20%
• Lung Cancer Cells 20%
• Lung Cancer Patients 20%
• Lung Tumorigenesis 20%
• Kinase Cascade 20%
• Phosphatidylinositol 3 20%
• Tumor Tissue 10%
• High-risk Human Papillomavirus (HR-HPV) 10%
• Taiwanese 10%
• Protein Level 10%
• Major Pathway 10%
• Immunostaining 10%
• Western Blot 10%
• Lung Tumor 10%
• Interleukin-6 Levels 10%
• A549 Lung Cancer Cells 10%
• Non-smoking 10%
• Paracrine 10%
• Female Lung Cancer 10%
• Interleukin-6 Expression 10%
• Regulating Effect 10%
• Mcl-1 Protein 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Non Small Cell Lung Cancer 100%
• Interleukin 6 100%
• Antiapoptotic 100%
• Human Papillomavirus Type 16 100%
• Lung Cancer 54%
• Papillomavirus Infection 27%
• Infection 18%
• Carcinogenesis 18%
• Phosphotransferase 18%
• Western Blot 9%
• Human Papillomavirus 9%
• Neoplasm 9%
• Enzyme-Linked Immunosorbent Assay 9%
• Lung Tumor 9%
• Protein Mcl 1 9%